Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kellogg Parsons

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Urology|June 15, 2007
Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problemsJ Kellogg Parsons
Urology|September 14, 2010
Editorial commentJ Kellogg Parsons
The Journal of Urology|January 18, 2015
Novel biomarkers and advanced imaging modalities in the early detection of prostate cancerJ Kellogg Parsons
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2013
Prostate cancer and the therapeutic benefits of structured exerciseJ Kellogg Parsons
Urology Practice|June 10, 2023
Editorial CommentaryJ Kellogg Parsons
The Journal of Urology|April 25, 2008
Commentary on BPH and public health--have we lost the forest through the trees?J Kellogg Parsons
The Journal of Urology|August 18, 2009
Editorial commentJ Kellogg Parsons
The Journal of Urology|January 24, 2017
Surgical Options for the Enlarged, Obstructing, Benign ProstateJ Kellogg Parsons
European Urology|June 11, 2013
Words of wisdom. Re: dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trialJ Kellogg Parsons
European Urology|July 6, 2013
High-intensity focused ultrasound for prostate cancer: tempering our enthusiasmJ Kellogg Parsons
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Urology|June 15, 2007
Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problemsJ Kellogg Parsons
Urology|September 14, 2010
Editorial commentJ Kellogg Parsons
The Journal of Urology|January 18, 2015
Novel biomarkers and advanced imaging modalities in the early detection of prostate cancerJ Kellogg Parsons
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2013
Prostate cancer and the therapeutic benefits of structured exerciseJ Kellogg Parsons
Urology Practice|June 10, 2023
Editorial CommentaryJ Kellogg Parsons
The Journal of Urology|April 25, 2008
Commentary on BPH and public health--have we lost the forest through the trees?J Kellogg Parsons
The Journal of Urology|August 18, 2009
Editorial commentJ Kellogg Parsons
The Journal of Urology|January 24, 2017
Surgical Options for the Enlarged, Obstructing, Benign ProstateJ Kellogg Parsons
European Urology|June 11, 2013
Words of wisdom. Re: dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trialJ Kellogg Parsons
European Urology|July 6, 2013
High-intensity focused ultrasound for prostate cancer: tempering our enthusiasmJ Kellogg Parsons
Pageof 18